Clinical Trial Update: Ocrelizumab Access by Socio-Economic Status

View source ↗

Summary

The report summarizes a completed clinical trial assessing access to ocrelizumab for multiple sclerosis patients across socio-economic groups.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Multiple Sclerosis | Status: COMPLETED